Supplement to "The risk of myocardial infarction, stroke and revascularization among patients with psoriasis treated with apremilast compared to biologics and DMARDs: a cohort study in the United States MarketScan database"

2020-03-20T06:58:53Z (GMT) by Rebecca Persson
Detailed Methods and Supplementary Tables for the Research Letter published in the Journal of the American Academy of Dermatology: The risk of myocardial infarction, stroke and revascularization among patients with psoriasis treated with apremilast compared to biologics and DMARDs: a cohort study in the United States MarketScan database

Categories

Keyword(s)

License

CC BY 4.0